HC Wainwright upgraded shares of HIVE Blockchain Technologies (CVE:HIV – Free Report) from a hold rating to a strong-buy rating in a report published on Thursday, Zacks.com reports.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies (CVE:HIV – Get Free Report) last posted its quarterly earnings results on Monday, June 24th. The company reported C($0.04) EPS for the quarter, topping the consensus estimate of C($0.18) by C$0.14. The firm had revenue of C$49.72 million for the quarter, compared to analyst estimates of C$53.64 million.
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Read More
- Five stocks we like better than HIVE Blockchain Technologies
- Find and Profitably Trade Stocks at 52-Week Lows
- This Small Cap Wealth Management Stock Could Provide Big Returns
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Top Biotech Stocks: Exploring Innovation Opportunities
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
